Stryker Corporation (SYK)

The past six months have seen several events impacting Stryker's stock price. A cyberattack in March 2026 disrupted Stryker's corporate network, causing an initial stock decline. Strong Q4 2025 results, reported in January, initially drove stock gains. Stryker's shares reached a 16-week high in February 2026, but later experienced drops following the cyberattack. Substantial insider selling contributed to negative sentiment.

Demand for Stryker's products and services is generally consistent and reliable, and not highly dependent on economic fluctuations. The company benefits from sustained demand across its product portfolio, driven by factors such as an aging global population, increasing surgical procedures, and a growing focus on healthcare outcomes.

Stryker Corporation is a multinational medical technologies corporation headquartered in Portage, Michigan, operating in the healthcare sector, specifically in health technology and medical devices. Stryker's mission is to make healthcare better by offering innovative products and services across Orthopaedics, MedSurg, and Neurotechnology and Spine. Major products include implants for joint replacements, surgical equipment, navigation systems, endoscopy, patient handling equipment, neurosurgical implants, and orthobiologic products.

Stryker has a significant global presence, selling products in over 75 countries and impacting 150 million patients annually. In 2024, 75% of revenues came from the United States. The company also operates across Europe, the Middle East, Africa, Asia Pacific, and other countries, focusing on international growth in developed and emerging markets like South Korea, Japan, Australia, and New Zealand.

Stryker's brand reputation in the past year has been primarily affected by the cyberattack in March 2026, which caused operational disruptions and raised cybersecurity concerns. Stryker's continued business in Russia during the 2022 invasion of Ukraine could have ongoing implications for its brand reputation among certain stakeholders.

Stryker's ownership is primarily composed of institutional investors, who collectively control approximately 78% to 79% of outstanding shares as of 2025. Major institutional shareholders include The Vanguard Group, BlackRock, Inc., and State Street Corporation. Significant individual owners and family members, such as Ronda Stryker, John W. Brown, and Jon Stryker, also retain influential stakes.